Researchers have used a urine test to identify and verify a patient's type of asthma, laying the foundation for a more personalised diagnosis and improved treatment.
The qualyfast DNA Extraction Kit, from Bioside, is a fast DNA extraction kit designed to detect Legionella in clear water samples. Extracted DNA can be directly used in downstream applications, including PCR and qPCR, without the need for further purification.
UK researchers have invented a COVID-19 test that is said to reduce testing time from 30 minutes to under five, while still delivering accurate results.
AdipoGen Life Sciences has developed a highly sensitive (1.8 pg/mL) and specific FGL1 (human) ELISA kit that can be used for the quantitative measurement of FGL1 in serum, plasma and cell culture supernatant samples.
CellBank Australia has released two cell lines for the study of chromatin architecture and dynamics. The HeLa derivatives are genetically modified to carry fluorescently tagged histone H2B proteins.
The Applied Biosystems TaqCheck SARS-CoV-2 Fast PCR Assay uses raw saliva samples and is designed to simplify lab workflows using instruments that are widely available to deliver data quickly.
BioAuxilium has developed its line of high-quality, fully validated Thunder cell signalling assays based on time-resolved Förster resonance energy transfer (TR-FRET) technology.
Tecan has launched the Crescendo cDNA Synthesis for qPCR system to provide increased sensitivity for low-input applications. It uses Tecan's Single Primer Isothermal Amplification (SPIA) technology to generate large quantities of cDNA from as little as 500 pg of total RNA.
StarBright Blue 700, StarBright Violet 440 and StarBright Violet 610 are fluorescent nanoparticles that are conjugated to Bio-Rad's highly validated flow antibodies, providing high brightness and resolution.
The LUNA-FX7 is claimed to provide unmatched cell counting accuracy, dual fluorescent and brightfield detection, advanced de-clustering algorithm, precision autofocus and 21 CFR PART 11 compliance.
The rollout of new, World Health Organization-approved, antigen-based rapid diagnostic tests for COVID-19 in Africa is expected to significantly boost testing capacity.
Cayman Chemical's ferroptosis suppressor protein 1 (FSP1) and glutathione peroxidase 4 (GPX4) inhibitor screening kits provide a robust and easy-to-use platform for identifying novel inhibitors of human FSP1 and GPX4, which are negative regulators of the ferroptosis pathway.